| 000 | 01659 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250512025100.0 | ||
| 264 | 0 | _c19860207 | |
| 008 | 198602s 0 0 eng d | ||
| 022 | _a0166-3542 | ||
| 024 | 7 |
_a10.1016/s0166-3542(85)80039-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKuwert, E | |
| 245 | 0 | 0 |
_aDose range study in healthy volunteers of a hepatitis B vaccine produced in yeast. _h[electronic resource] |
| 260 |
_bAntiviral research _c1985 |
||
| 300 |
_a281-8 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntigens, Viral _ximmunology |
| 650 | 0 | 4 | _aDNA, Recombinant |
| 650 | 0 | 4 | _aDose-Response Relationship, Immunologic |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis B _ximmunology |
| 650 | 0 | 4 |
_aHepatitis B Antibodies _xbiosynthesis |
| 650 | 0 | 4 |
_aHepatitis B Surface Antigens _xadministration & dosage |
| 650 | 0 | 4 | _aHepatitis B Vaccines |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization, Secondary |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 |
_aSaccharomyces cerevisiae _xgenetics |
| 650 | 0 | 4 | _aTransformation, Genetic |
| 650 | 0 | 4 | _aVaccination |
| 650 | 0 | 4 |
_aViral Hepatitis Vaccines _xadministration & dosage |
| 700 | 1 | _aScheiermann, N | |
| 700 | 1 | _aGesemann, M | |
| 700 | 1 | _aPaar, D | |
| 700 | 1 | _aSafary, A | |
| 700 | 1 | _aSimoen, E | |
| 700 | 1 | _aHauser, P | |
| 700 | 1 | _aAndre, F | |
| 773 | 0 |
_tAntiviral research _gvol. Suppl 1 _gp. 281-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0166-3542(85)80039-5 _zAvailable from publisher's website |
| 999 |
_c2940922 _d2940922 |
||